In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species
- PMID: 8843312
- PMCID: PMC163448
- DOI: 10.1128/AAC.40.8.1948
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species
Abstract
A new triazole derivative (voriconazole or UK-109,496) and fluconazole were tested against 249 isolates of Candida spp. representing six species. Voriconazole was 10 to 100 times more potent than fluconazole. Strains with decreased susceptibility to fluconazole were inhibited by relatively low concentrations of voriconazole.
Similar articles
-
A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.Antimicrob Agents Chemother. 1997 Nov;41(11):2492-6. doi: 10.1128/AAC.41.11.2492. Antimicrob Agents Chemother. 1997. PMID: 9371355 Free PMC article.
-
Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.Eur J Clin Microbiol Infect Dis. 1999 Jun;18(6):432-5. doi: 10.1007/s100960050313. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10442422
-
The effect of the new triazole, voriconazole (UK-109,496), on the interactions of Candida albicans and Candida krusei with endothelial cells.J Chemother. 1998 Feb;10(1):7-16. doi: 10.1179/joc.1998.10.1.7. J Chemother. 1998. PMID: 9531069
-
Conazoles.Molecules. 2010 Jun 9;15(6):4129-88. doi: 10.3390/molecules15064129. Molecules. 2010. PMID: 20657432 Free PMC article. Review.
-
1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review.Curr Top Med Chem. 2020;20(24):2235-2258. doi: 10.2174/1568026620666200704140107. Curr Top Med Chem. 2020. PMID: 32621720 Review.
Cited by
-
Voriconazole-induced periostitis: a new rheumatic disorder.Clin Rheumatol. 2017 Mar;36(3):609-615. doi: 10.1007/s10067-016-3341-7. Epub 2016 Jul 4. Clin Rheumatol. 2017. PMID: 27376754 Review.
-
DectiSomes: C-type lectin receptor-targeted liposomes as pan-antifungal drugs.Adv Drug Deliv Rev. 2023 May;196:114776. doi: 10.1016/j.addr.2023.114776. Epub 2023 Mar 17. Adv Drug Deliv Rev. 2023. PMID: 36934519 Free PMC article. Review.
-
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.Antimicrob Agents Chemother. 1997 Mar;41(3):575-7. doi: 10.1128/AAC.41.3.575. Antimicrob Agents Chemother. 1997. PMID: 9055995 Free PMC article.
-
Use of voriconazole in treatment of Scedosporium apiospermum infection: case report.J Clin Microbiol. 1998 May;36(5):1436-8. doi: 10.1128/JCM.36.5.1436-1438.1998. J Clin Microbiol. 1998. PMID: 9574724 Free PMC article.
-
Comparison of high-performance liquid chromatographic and microbiological methods for determination of voriconazole levels in plasma.Antimicrob Agents Chemother. 2000 May;44(5):1209-13. doi: 10.1128/AAC.44.5.1209-1213.2000. Antimicrob Agents Chemother. 2000. PMID: 10770753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous